BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1494 related articles for article (PubMed ID: 25543972)

  • 1. Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.
    Mentz RJ; Stevens SR; DeVore AD; Lala A; Vader JM; AbouEzzeddine OF; Khazanie P; Redfield MM; Stevenson LW; O'Connor CM; Goldsmith SR; Bart BA; Anstrom KJ; Hernandez AF; Braunwald E; Felker GM
    JACC Heart Fail; 2015 Feb; 3(2):97-107. PubMed ID: 25543972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The predictability of renin-angiotensin-aldosterone system factors for clinical outcome in patients with acute decompensated heart failure.
    Nakada Y; Takahama H; Kanzaki H; Sugano Y; Hasegawa T; Ohara T; Amaki M; Funada A; Yoshida A; Yasuda S; Ogawa H; Anzai T
    Heart Vessels; 2016 Jun; 31(6):925-31. PubMed ID: 25964073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per-protocol analysis of CARRESS-HF.
    Grodin JL; Carter S; Bart BA; Goldsmith SR; Drazner MH; Tang WHW
    Eur J Heart Fail; 2018 Jul; 20(7):1148-1156. PubMed ID: 29493059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD.
    Costanzo MR; Saltzberg MT; Jessup M; Teerlink JR; Sobotka PA;
    J Card Fail; 2010 Apr; 16(4):277-84. PubMed ID: 20350693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial Differences in Diuretic Efficiency, Plasma Renin, and Rehospitalization in Subjects With Acute Heart Failure.
    Morris AA; Nayak A; Ko YA; D'Souza M; Felker GM; Redfield MM; Tang WHW; Testani JM; Butler J
    Circ Heart Fail; 2020 Jul; 13(7):e006827. PubMed ID: 32635768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Ultrafiltration on Serum Sodium Homeostasis and its Clinical Implication in Patients With Acute Heart Failure, Congestion, and Worsening Renal Function.
    Kitai T; Grodin JL; Kim YH; Tang WH
    Circ Heart Fail; 2017 Feb; 10(2):e003603. PubMed ID: 28130379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: an analysis from diuretic optimization strategies in acute heart failure.
    Shah RV; McNulty S; O'Connor CM; Felker GM; Braunwald E; Givertz MM
    Am Heart J; 2012 Dec; 164(6):862-8. PubMed ID: 23194486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF).
    Lala A; McNulty SE; Mentz RJ; Dunlay SM; Vader JM; AbouEzzeddine OF; DeVore AD; Khazanie P; Redfield MM; Goldsmith SR; Bart BA; Anstrom KJ; Felker GM; Hernandez AF; Stevenson LW
    Circ Heart Fail; 2015 Jul; 8(4):741-8. PubMed ID: 26041600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
    Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
    Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluid removal in acute heart failure: diuretics versus devices.
    Krishnamoorthy A; Felker GM
    Curr Opin Crit Care; 2014 Oct; 20(5):478-83. PubMed ID: 25111680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure.
    Paterna S; Parrinello G; Cannizzaro S; Fasullo S; Torres D; Sarullo FM; Di Pasquale P
    Am J Cardiol; 2009 Jan; 103(1):93-102. PubMed ID: 19101237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure.
    Kociol RD; McNulty SE; Hernandez AF; Lee KL; Redfield MM; Tracy RP; Braunwald E; O'Connor CM; Felker GM;
    Circ Heart Fail; 2013 Mar; 6(2):240-5. PubMed ID: 23250981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin-Angiotensin-Aldosterone System Activation and Diuretic Response in Ambulatory Patients With Heart Failure.
    Amatruda JG; Scherzer R; Rao VS; Ivey-Miranda JB; Shlipak MG; Estrella MM; Testani JM
    Kidney Med; 2022 Jun; 4(6):100465. PubMed ID: 35620081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized Evaluation of Heart Failure With Preserved Ejection Fraction Patients With Acute Heart Failure and Dopamine: The ROPA-DOP Trial.
    Sharma K; Vaishnav J; Kalathiya R; Hu JR; Miller J; Shah N; Hill T; Sharp M; Tsao A; Alexander KM; Gupta R; Montemayor K; Kovell L; Chasler JE; Lee YJ; Fine DM; Kass DA; Weiss RG; Thiemann DR; Ndumele CE; Schulman SP; Russell SD;
    JACC Heart Fail; 2018 Oct; 6(10):859-870. PubMed ID: 30098962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of Diuretic Responsiveness and Associated Outcomes During Acute Heart Failure Hospitalization: An Analysis From the NHLBI Heart Failure Network Clinical Trials.
    Kiernan MS; Stevens SR; Tang WHW; Butler J; Anstrom KJ; Birati EY; Grodin JL; Gupta D; Margulies KB; LaRue S; Dávila-Román VG; Hernandez AF; de Las Fuentes L;
    J Card Fail; 2018 Jul; 24(7):428-438. PubMed ID: 29482026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma renin activity is a strong and independent prognostic indicator in patients with acute decompensated heart failure treated with renin-angiotensin system inhibitors.
    Ueda T; Kawakami R; Nishida T; Onoue K; Soeda T; Okayama S; Takeda Y; Watanabe M; Kawata H; Uemura S; Saito Y
    Circ J; 2015; 79(6):1307-14. PubMed ID: 25753468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure.
    Rogers HL; Marshall J; Bock J; Dowling TC; Feller E; Robinson S; Gottlieb SS
    J Card Fail; 2008 Feb; 14(1):1-5. PubMed ID: 18226766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a role for renin profiling in selecting chronic heart failure patients for ACE inhibitor treatment?
    Lim PO; MacFadyen RJ; Struthers AD
    Heart; 2000 Mar; 83(3):257-61. PubMed ID: 10677399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum to urinary sodium concentration ratio is an estimate of plasma renin activity in congestive heart failure.
    Marenzi G; Lauri G; Assanelli E; Grazi M; Campodonico J; Famoso G; Agostoni P
    Eur J Heart Fail; 2002 Oct; 4(5):597-603. PubMed ID: 12413503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 75.